ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) announced financial results for the fourth quarter ended December 31, 2015, and provided an update on the Company’s recent …
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), a biopharmaceutical company focused on new cancer immunotherapies, today announced the publication of a study in Scientific Reports, a journal …
Healthcare analysts are out with commentary on biotech stocks Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and ZIOPHARM Oncology Inc. (NASDAQ:ZIOP).
Concluding another successful year, the 2016 JP Morgan Healthcare Conference has seen its share of announcements, discoveries and unveiling of things to come. Among …
Two clinical stage biopharmaceutical companies, Arrowhead Research Corp (NASDAQ:ARWR) and ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), both provided a data update on pipeline drugs.
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) was up 9% in pre-market trading this morning following positive data from its CD19-specifict CAR T-cell therapy programs.
CTI BioPharma Corp CTI BioPharma Corp (NASDAQ:CTIC) shares are tumbling 16.24% to $0.
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), a biopharmaceutical company focused on new cancer immunotherapies, today announced that the Company is presenting initial results from an ongoing Phase …
In a research note released Thursday, J.P.
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) announced financial results for the third quarter ended September 30, 2015, and provided an update on the company’s recent …
